Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
Sarcoma Oncology Research Center, LLC
TopAlliance Biosciences
National Cancer Institute (NCI)
Cellestia Biotech AG
Eli Lilly and Company
Pfizer
INSYS Therapeutics Inc